| RS796052063 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052064 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052065 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052066 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052067 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052068 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS796052069 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052070 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052071 |
AGXT
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type I |
| RS796052072 |
AGXT
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type I |
| RS796052074 |
AGXT
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type I |
| RS796052077 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS796052078 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS796052079 |
GRHPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria, type II |
| RS796052081 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS796052082 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS796052084 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052085 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052086 |
HOGA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052087 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052088 |
HOGA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052089 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052090 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052091 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052092 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS796052093 |
COL12A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 2, Ullrich congenital muscular dystrophy 2 |
| RS796052094 |
COL12A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 2, Bethlem myopathy 2 |
| RS796052095 |
AFG2A
|
Health Risk |
Pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS796052096 |
AVPR2
|
Health Risk |
Pathogenic |
Diabetes insipidus, nephrogenic |
| RS796052116 |
LTBP3
|
Health Risk |
Pathogenic |
Brachyolmia-amelogenesis imperfecta syndrome, Brachyolmia-amelogenesis imperfecta syndrome |
| RS796052117 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS796052118 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS796052119 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS796052121 |
NBAS
|
Health Risk |
Likely pathogenic |
Infantile liver failure syndrome 2, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS796052122 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS796052123 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS796052124 |
POLR1C
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS796052125 |
POLR1C
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS796052126 |
POLR1C
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 11, Hypomyelinating leukodystrophy 11 |
| RS796052127 |
POLR1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 11, Treacher Collins syndrome 3 |
| RS796052128 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, KIAA0586-related disorder |
| RS796052129 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS796052130 |
UFSP2
|
Health Risk |
Pathogenic |
Hip dysplasia, Beukes type |
| RS796052133 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS796052134 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease type 2, Maple syrup urine disease type 2 |
| RS796052135 |
DBT
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS796052136 |
CFH
|
Health Risk |
risk factor |
Hemolytic uremic syndrome, atypical |
| RS796052137 |
CFH
|
Health Risk |
Pathogenic, low penetrance |
Hemolytic uremic syndrome, atypical |
| RS796052138 |
CFH
|
Health Risk |
Pathogenic |
Factor H deficiency, Factor H deficiency |
| RS796052139 |
SLC29A3
|
Health Risk |
Pathogenic |
H syndrome, H syndrome |
| RS796052166 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052171 |
CAV3
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052196 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052197 |
ANK2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052198 |
ANK2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052199 |
AKAP9
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052200 |
AKAP9
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS796052212 |
UBE2T
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group T, Fanconi anemia complementation group T |
| RS796052213 |
SQSTM1
|
Health Risk |
Pathogenic |
Paget disease of bone 3, Paget disease of bone 3 |
| RS796052215 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS796052216 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS796052217 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Global developmental delay, Speech apraxia |
| RS796052219 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS796052220 |
POGZ
|
Health Risk |
Pathogenic |
— |
| RS796052221 |
POGZ
|
Health Risk |
Likely pathogenic |
— |
| RS796052224 |
DDX3X
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS796052226 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental abnormality, Intellectual disability |
| RS796052227 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS796052230 |
DDX3X
|
Health Risk |
Pathogenic |
Rare genetic intellectual disability, Intellectual disability |
| RS796052231 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS796052232 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS796052233 |
DDX3X
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 102 |
| RS796052234 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS796052235 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS796052236 |
DDX3X
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Intellectual disability |
| RS796052238 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS796052240 |
ARID2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS796052241 |
ARID2
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS796052242 |
ARID2
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 6, Coffin-Siris syndrome 6 |
| RS796052243 |
AFG2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS796052244 |
ADSL
|
Health Risk |
Likely pathogenic |
— |
| RS796052246 |
ADSL
|
Health Risk |
Pathogenic |
— |
| RS796052247 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS796052248 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS796052252 |
ADSL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS796052255 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS796052256 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Inborn genetic diseases |
| RS796052260 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS796052267 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS796052269 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Inborn genetic diseases |
| RS796052270 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, ALDH7A1-related disorder |
| RS796052271 |
ALDH7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS796052277 |
ATP1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 98, Migraine |
| RS796052303 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS796052305 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS796052307 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, CHRNA2-related disorder |
| RS796052312 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS796052314 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS796052317 |
CHRNA4
|
Health Risk |
Likely pathogenic |
— |
| RS796052318 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 1, Tobacco addiction |